§ 13F · FUND PROFILE
Foresite Capital Management VI LLC.
AUM · $643M (13F)Positions · 23Turnover · n/a · Q2Filed · Aug 14, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
+$101M deployed
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS
The book · Q2 2026
FILED AUG 14, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q2 |
|---|---|---|---|---|---|---|
| 1 | CGON | CG Oncology, Inc. | 2.37M | $168M | 26.2% | +7% |
| 2 | ALMS | ALUMIS INC. | 4.25M | $120M | 18.6% | ±0% |
| 3 | SPTX | Seaport Therapeutics, Inc. | 1.78M | $39M | 6.0% | NEW |
| 4 | DNLI | Denali Therapeutics Inc. | 1.40M | $36M | 5.6% | +15% |
| 5 | CLDX | Celldex Therapeutics, Inc. | 880K | $33M | 5.1% | +178% |
| 6 | AGIO | AGIOS PHARMACEUTICALS, INC. | 785K | $29M | 4.5% | +50% |
| 7 | CRVS | Corvus Pharmaceuticals, Inc. | 1.83M | $27M | 4.3% | ±0% |
| 8 | PBLS | Parabilis Medicines, Inc. | 999K | $27M | 4.3% | NEW |
| 9 | GHRS | GH Research PLC | 940K | $25M | 3.9% | +198% |
| 10 | JBIO | Jade Biosciences, Inc. | 887K | $20M | 3.1% | +177% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE FORESITE SIGNAL
AC read
Foresite Capital Management VI LLC is a Other fund managing $643 million in assets. The fund runs a focused portfolio of just 23 positions.
Read the full dossier →